13 Although this might depict improved getting performance for payers and sufferers, it places economical pressure on institutions which have historically relied on generic drug margins to remain successful, such as impartial pharmacies and wholesalers.14 one particular spot of interest to policymakers continues to be wholesalers’ roles in exace